Written and maintained by CASRAI Editorial Board
Last updated
Clinical & Research Documentation Notice: This reference provides standardized behavioral health intake templates, psychometric coding mappings, and health informatics schemas for clinical documentation and research protocol design. It does not constitute patient-specific medical or psychiatric advice.
Behavioral health clinicians, psychiatric researchers, and clinical informatics architects designing a biopsychosocial assessment template (or biopsychosocial intake form) operationalize the tri-axial clinical model originally formulated by George L. Engel (Science, 1977) and codified in the American Psychiatric Association (APA) Practice Guidelines for the Psychiatric Evaluation of Adults. Unlike a brief follow-up SOAP note, a comprehensive initial biopsychosocial evaluation synthesizes somatic/pharmacological factors, psychological/developmental history, and social determinants of health (SDOH) alongside a structured Mental Status Examination (MSE) and quantitative risk scales such as the Columbia-Suicide Severity Rating Scale (C-SSRS).
What Should Be Included in a Biopsychosocial Assessment Template?
A complete biopsychosocial assessment template is organized into seven core clinical sections so that accrediting bodies (such as The Joint Commission and CARF), payers, and multi-site psychiatric clinical trials capture both narrative clinical context and discrete, auditable risk indicators:
| Assessment Section | Required Clinical Elements | Standardized Scales & LOINC Panel Codes |
|---|---|---|
| 1. Identifying Data, Chief Complaint & HPI | Demographics, referral source, patient’s verbatim chief complaint, onset, duration, precipitating stressors, and baseline functional impairment. | LOINC 10154-3 (Chief complaint), LOINC 10164-2 (History of present illness) |
| 2. Biological Domain | Active and historical medical conditions, neurological/endocrine disorders, surgical history, current psychotropic and somatic medications (dose, adherence, adverse effects), allergies, sleep/appetite/pain physiology, substance use inventory, and family genetic/psychiatric history. | LOINC 10160-0 (History of Medication use), LOINC 11369-6 (History of Immunization/Allergies), AUDIT-C (LOINC 75626-2), DAST-10 |
| 3. Psychological Domain | Prior outpatient/inpatient psychiatric history, developmental milestones, trauma and adverse childhood experiences (ACEs), personality traits, defense and coping mechanisms, cognitive schemas, and quantitative mood/anxiety symptom severity. | PHQ-9 (LOINC 44249-1, score 44261-6), GAD-7 (LOINC 69737-5, score 70274-6), HoNOS |
| 4. Social & Environmental Domain | Housing stability, household composition, marital/family support network, educational attainment, occupational/financial status, military/legal history, cultural/spiritual identity, and protective factors. | PRAPARE SDOH Panel (LOINC 93025-5), CMS AHC HRSN Screener (LOINC 96777-8) |
| 5. Mental Status Examination (MSE) | Objective point-in-time behavioral observation: Appearance, Behavior/Psychomotor activity, Speech, Mood (subjective) and Affect (objective), Thought Process, Thought Content, Perceptual Disturbances, Cognition/Orientation, Insight, and Judgment. | LOINC 10190-7 (Mental status Narrative) |
| 6. Suicide, Self-Harm & Violence Risk Screening | Structured ideation, intent, plan, preparatory behavior, past attempts, access to lethal means, and acute protective factors. | C-SSRS Recent Screener (LOINC 93373-9; items 93246-7 to 93250-9, 93267-3; risk level 93374-7) |
| 7. Integrative 4Ps Formulation, DSM-5-TR Diagnosis & Plan | Cross-matrix mapping Predisposing, Precipitating, Perpetuating, and Protective (4Ps) factors across Biological, Psychological, and Social axes, DSM-5-TR / ICD-10-CM diagnoses, and measurable treatment goals. | LOINC 51848-0 (Evaluation note), LOINC 18776-5 (Plan of care note) |
Copy-Ready Biopsychosocial Assessment Template & Intake Form
Clinical practices and behavioral health research sites can adapt the following structured template for initial psychiatric, psychotherapy, or behavioral medicine intakes:
================================================================================
BIOPSYCHOSOCIAL CLINICAL ASSESSMENT & INTAKE FORM
================================================================================
1. ADMINISTRATIVE & IDENTIFYING INFORMATION
Patient ID / MRN: ______________________ Encounter Date/Time: _____________
Age / Sex / Pronouns: __________________ Preferred Language: ______________
Referral Source: _______________________ Informant(s) & Reliability: ______
2. CHIEF COMPLAINT & HISTORY OF PRESENT ILLNESS (HPI)
Chief Complaint (Patient's own words): "____________________________________"
Onset, Duration & Course: ___________________________________________________
Current Symptom Severity & Functional Impact (Work/School/ADLs): ____________
3. BIOLOGICAL DOMAIN
• Active Medical / Neurological Conditions: _________________________________
• Current Medications (Name, Dose, Route, Frequency, Adherence): ____________
• Allergies & Adverse Drug Reactions: _______________________________________
• Vegetative Functions (Sleep hours/quality, Appetite/Weight, Energy, Pain): _
• Substance Use History (Alcohol, Tobacco/Nicotine, Cannabis, Opioids,
Stimulants, Sedatives, Caffeine — Age of first use, amount, last use): ____
• Family Psychiatric, Substance Use & Medical History: ______________________
4. PSYCHOLOGICAL DOMAIN
• Past Psychiatric History (Prior diagnoses, outpatient therapy, inpatient
hospitalizations, partial hospitalization/IOP, past medication trials): ___
• Trauma & Abuse History (Physical, emotional, sexual, neglect, combat/witness):
___________________________________________________________________________
• Developmental History & Cognitive Baseline: _______________________________
• Coping Mechanisms, Strengths & Cognitive Style: ___________________________
• Standardized Symptom Scales:
- PHQ-9 Score: ____ / 27 - GAD-7 Score: ____ / 21
5. SOCIAL, CULTURAL & ENVIRONMENTAL DOMAIN
• Living Situation & Housing Stability: _____________________________________
• Family Structure, Intimate Relationships & Social Support: ________________
• Education & Employment / Financial Stressors: _____________________________
• Legal / Military / Justice Involvement: ___________________________________
• Cultural, Religious/Spiritual & Identity Factors: _________________________
6. MENTAL STATUS EXAMINATION (MSE)
• Appearance & Grooming: [ ] Well-groomed [ ] Disheveled [ ] Other: _______
• Behavior & Psychomotor: [ ] Cooperative [ ] Agitated [ ] Retarded
• Speech (Rate/Volume/Tone): [ ] Normal [ ] Pressured [ ] Slow/Paucity
• Mood (Subjective): "_______________" Affect: [ ] Euthymic [ ] Constricted
[ ] Depressed [ ] Anxious [ ] Labile [ ] Blunted/Flat (Congruent? Y / N)
• Thought Process: [ ] Linear/Goal-directed [ ] Circumstantial [ ] Tangential
• Thought Content: [ ] No SI/HI/Delusions [ ] Obsessions [ ] Paranoia
• Perceptual Disturbances: [ ] Denies AVH [ ] Auditory [ ] Visual
• Cognition & Orientation: [ ] Alert & Oriented x4 Memory/Attention: _______
• Insight: [ ] Good [ ] Fair [ ] Poor Judgment: [ ] Good [ ] Fair [ ] Poor
7. RISK ASSESSMENT (C-SSRS RECENT SCREENER — PAST MONTH)
1. Wish to be dead (LOINC 93246-7): [ ] No [ ] Yes
2. Non-specific active suicidal thoughts (LOINC 93247-5): [ ] No [ ] Yes
3. Active SI with any methods, no intent (LOINC 93248-3): [ ] No [ ] Yes
4. Active SI with some intent, no plan (LOINC 93249-1): [ ] No [ ] Yes
5. Active SI with specific plan and intent (LOINC 93250-9): [ ] No [ ] Yes
6. Lifetime/Recent Preparatory or Suicidal Behavior (93267-3): [ ] No [ ] Yes
• Access to Lethal Means (Firearms, stockpiled medications): ________________
• Homicidal Ideation / Duty-to-Warn Risk: [ ] Denies [ ] Present: __________
• Overall Acute Risk Stratification (LOINC 93374-7): [ ] Low [ ] Mod [ ] High
8. INTEGRATIVE 4Ps BIOPSYCHOSOCIAL FORMULATION & TREATMENT PLAN
• Predisposing Factors (Bio/Psycho/Social): _________________________________
• Precipitating Factors (Bio/Psycho/Social): ________________________________
• Perpetuating Factors (Bio/Psycho/Social): _________________________________
• Protective Factors (Bio/Psycho/Social): ___________________________________
• DSM-5-TR / ICD-10-CM Diagnoses: ___________________________________________
• Level of Care, Safety Plan & Initial Treatment Modalities: ________________
================================================================================Worked Example: The 4Ps Biopsychosocial Case Formulation Matrix
The clinical value of a biopsychosocial assessment lies in synthesizing raw intake findings into an actionable 4Ps Formulation Matrix (crossing Predisposing, Precipitating, Perpetuating, and Protective factors with the Biological, Psychological, and Social axes). Below is a de-identified illustrative matrix for a 34-year-old outpatient presenting with a major depressive episode:
| 4Ps Dimension | Biological Axis | Psychological Axis | Social & Environmental Axis |
|---|---|---|---|
| Predisposing (Underlying vulnerabilities) |
First-degree family history of Major Depressive Disorder (mother) and hypothyroidism. | Perfectionistic cognitive schema and avoidant coping style developed in early adolescence. | Geographic relocation 18 months ago with loss of local extended family support network. |
| Precipitating (Acute triggers) |
Post-viral sleep disruption and discontinuation of levothyroxine 3 months ago due to lapsed insurance. | Perceived personal failure following an unexpected corporate layoff 8 weeks ago. | Acute household financial strain and loss of employer-sponsored healthcare coverage. |
| Perpetuating (Maintaining factors) |
Untreated subclinical hypothyroidism (TSH 7.8 mIU/L), circadian phase delay (sleeping 03:00–11:00), and physical inactivity. | Ruminative self-blame, behavioral withdrawal from pleasurable activities, and catastrophic future forecasting. | Social isolation while working gig shifts alone; reluctance to disclose job loss to spouse/family. |
| Protective (Strengths & buffers) |
No substance use disorder, no chronic pain, prior positive response to sertraline 100 mg daily. | High treatment motivation, intact insight/judgment, and negative C-SSRS suicide risk screen. | Supportive marriage, stable housing, and newly activated state Medicaid coverage. |
How Is a Biopsychosocial Assessment Template Structured in EHR Workflows?
In modern behavioral health EHRs and clinical trial Electronic Data Capture (EDC) systems built on HL7® FHIR® R4, a biopsychosocial intake is implemented using the FHIR Structured Data Capture (SDC) implementation guide:
- FHIR `Questionnaire` and `QuestionnaireResponse`: The blank biopsychosocial intake form is defined as a canonical FHIR `Questionnaire` resource containing nested `group` items (`biological-domain`, `psychological-domain`, `social-domain`, `mse-domain`, `cssrs-recent-panel`). When completed during patient pre-registration or clinician charting, the answers are stored in a `QuestionnaireResponse` resource.
- Automated Extraction to Discrete FHIR `Observation` and `Condition` Resources: Using the SDC `$extract` operation, scored panels embedded inside the intake—such as PHQ-9 (`LOINC 44261-6`), GAD-7 (`LOINC 70274-6`), and C-SSRS (`LOINC 93374-7`)—automatically generate discrete `Observation` resources so longitudinal symptom trajectories can be graphed across subsequent psychotherapy or pharmacotherapy visits.
- Separation from Psychotherapy Process Notes (45 CFR § 164.501): Because a biopsychosocial intake documents medication history, symptoms, functional status, diagnosis, and treatment plan, it forms part of the designated medical record rather than a separated HIPAA “psychotherapy note” under 45 CFR § 164.501.
Frequently Asked Questions
What should be included in a biopsychosocial assessment template?
A comprehensive biopsychosocial assessment template includes seven core sections: (1) Identifying information, chief complaint, and history of present illness (HPI); (2) Biological domain (medical conditions, medications, sleep/appetite, substance use, and family genetic history); (3) Psychological domain (psychiatric history, trauma, coping style, and PHQ-9/GAD-7 scores); (4) Social domain (housing, relationships, employment, legal, and cultural factors); (5) Mental Status Examination (MSE); (6) Suicide and violence risk assessment (such as the C-SSRS screener); and (7) an integrative 4Ps biopsychosocial formulation with DSM-5-TR / ICD-10-CM diagnoses and treatment plan.
How is a biopsychosocial assessment template structured in EHR workflows?
In HL7 FHIR R4 EHR workflows, the template is authored as a FHIR Questionnaire resource with nested item groups mapped to LOINC codes (such as LOINC 93373-9 for the C-SSRS screener, 44249-1 for PHQ-9, and 93025-5 for PRAPARE social determinants). Completed intakes are stored as QuestionnaireResponse resources and extracted into discrete FHIR Observation, Condition, and CarePlan resources for longitudinal tracking.
